Back to search
FDAFDA · Food and drugs·Recall number Z-2339-2017

VIDAS Testosterone, Ref 30418

Published July 19, 2017 · Recall initiated: May 15, 2017

Summary

FDA records medical device Class II recall Z-2339-2017, published July 19, 2017 and initiated May 15, 2017. Recalling firm: bioMerieux, Inc.; Status: Terminated; Reported quantity: 742; Lot: Lots 1004878310 & 1005001080. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Complaints were received from customers observing falsely overestimate results or external quality control higher results than expected when performing tests with VIDAS Testosterone.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
bioMerieux, Inc.
Distributor
AR, CA, CO, GA, IL, IA, MI, MN, MT, NY, OK, TN, TX, WY, Columbia, Costa Rica, El Salvador, France, Hong Kong, Jordan, Nicaragua, Russian Fed., Sri Lanka, Sweden, Ukraine
Lot
Lots 1004878310 & 1005001080
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was VIDAS Testosterone, Ref 30418 recalled?

Yes. FDA published recall Z-2339-2017 on July 19, 2017. Reported hazard: Complaints were received from customers observing falsely overestimate results or external quality control higher results than expected when performing tests with VIDAS Testosterone.

What should I do if I have this product?

Voluntary: Firm initiated · Letter